FDA Roundup: January 14, 2025
- Today, the FDA issued a Request for Information (RFI) on industry practices related to poppy seeds. The FDA is interested in better understanding the agricultural, industry, manufacturing, and supply chain practices currently being used, and whether certain practices increase or reduce the presence of opiate alkaloids on poppy seeds.
- Today, the FDA's Center for Veterinary Medicine issued a Dear Veterinarian letter alerting practitioners to the possibility of burns associated with the use of Megadyne grounding pads in animal surgical patients.
- On Monday, the FDA published the FDA Voices, "Vaccines for COVID-19: A Personal Reflection," by
Robert M. Califf , MD, Commissioner of Food and Drugs. This FDA Voices isDr. Califf's personal reflection on the status of COVID vaccines, which he says constitute one of the most important elements of government policy, particularly as it relates to the FDA and his term as Commissioner. It is not intended to be an exhaustive systematic review or to represent the policies of the current administration. - On Monday, the FDA published the blog, "FDA Spearheads Global Efforts on Informal Markets and Substandard/Falsified Medical Products." This blog is the latest in the "From A Global Perspective" series and discusses the FDA's role in leading WHO efforts to address knowledge gaps regarding the global distribution of substandard and falsified medical products through informal/unregulated markets.
- On Friday, the FDA,
U.S. Homeland Security Investigations, and U.S. Customs and Border Protection announced the seizure of more than 628,000 unauthorized e-cigarette products from a warehouse inMiami . The seized products—mostly flavored, disposable e-cigarettes as well as some packs, kits, and batteries—were valued at more than$7 million and included some brands that may appeal to youth, such as Geek Bar. This seizure is another example of coordinated enforcement actions across federal agencies to curb the distribution and sale of illegal e-cigarettes.
Additional Resources:
Media Contact: FDA Office of Media Affairs, 301-796-4540
Consumer Inquiries: 888-INFO-FDA
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, radiation-emitting electronic products, and for regulating tobacco products.
View original content to download multimedia:https://www.prnewswire.com/news-releases/fda-roundup-january-14-2025-302350947.html
SOURCE U.S. Food and Drug Administration
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Federal Signal Provides Update on Streator, Illinois Facility; Announces Signing of Definitive Agreement to Acquire Western Technology, Expanding its Presence in Portable Industrial Signaling Solution
- J. Colby Williams to Succeed Jeffrey Welch as Executive Vice President and General Counsel at Red Rock Resorts
- Hydro One seeks approval from the Ontario Energy Board to build the Durham Kawartha Power Line
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share